gw870086
Small moleculeexperimental
Clinical trial activity
8 trials · 1 clinical orgs · 0 marketing orgs
Phase 1
4
Phase 2
4
Phase 3
0
Phase 4
0
Earliest trial started Oct 1, 2005 (NCT00483899)
Timeline
Indications
Studied for
Mechanism of action
- Glucocorticoid receptorAGONIST
NR3C1 agonist
Chemistry & pharmacology
Oral
No
Parenteral
No
Topical
No
Also known as
- gw870086
- gw870086
- gw870086x
- gw870086x
Clinical trials
| NCT ID | Phase | Start date | Sponsor(s) |
|---|---|---|---|
| NCT01381445 | Phase 1 | Apr 1, 2011 | GlaxoSmithKline |
| NCT01245426 | Phase 2 | Dec 1, 2010 | GlaxoSmithKline |
| NCT01299610 | Phase 2 | Dec 1, 2010 | GlaxoSmithKline |
| NCT01160003 | Phase 1 | Jul 29, 2010 | GlaxoSmithKline |
| NCT00945932 | Phase 2 | Jul 1, 2009 | GlaxoSmithKline |
| NCT00857857 | Phase 2 | Feb 1, 2009 | GlaxoSmithKline |
| NCT00549497 | Phase 1 | Sep 1, 2007 | GlaxoSmithKline |
| NCT00483899 | Phase 1 | Oct 1, 2005 | GlaxoSmithKline |
Showing 8 of 8 trials
Page 1 / 1
Organizations
Research & Development (1)
| Organization | Org type | Trials | As lead sponsor | Phases | Earliest year |
|---|---|---|---|---|---|
| GlaxoSmithKline | For profit | 8 | 8 | 2 | 2005 |
1 organizations
Page 1 / 1